UroLift® System for BPH
What is BPH?
Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. Over 70% of men in their 60s have BPH symptoms so it is very common1. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life.
The prostate is a male reproductive gland, about the size of a walnut, that produces fluid for semen. The prostate surrounds the urethra, which is the tube that carries urine from the bladder out of the body. As the prostate enlarges, it presses on and blocks the urethra, causing bothersome urinary symptoms such as:
- Frequent need to urinate both day and night
- Weak or slow urinary stream
- A sense that you cannot completely empty your bladder
- Difficulty or delay in starting urination
- Urgent feeling of needing to urinate
- A urinary stream that stops and starts
If you suffer from the above symptoms, you are not alone. BPH is one of the leading reasons for men to visit a urologist.
What is the UroLift® System?
The UroLift® System is a new, minimally invasive approach to treating BPH for patients looking for an alternative to drug therapy or more invasive surgery. The UroLift System is a straightforward procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue.
The UroLift System is clinically proven to be safe and effective and provides rapid symptom relief.2 Typically, the procedure is done in the physician’s office under local anesthesia and does not require a catheter to be placed. A unique benefit of the UroLift System is that it preserves a man’s sexual function.1 The goal is to relieve you of bothersome urinary symptoms so you can get back to your life and resume daily activities.
Clinical studies have demonstrated that the UroLift procedure provides a similar level of symptom relief (compared with other BPH procedures), with fewer side effects.2 Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
For more information about UroLift System treatment contact us.
How the UroLift System Works
An enlarged prostate compresses on the urethra, making it difficult for urine to flow.
|The UroLift Device is placed through the obstructed urethra to access the enlarged prostate.
|The device compresses the tissue and delivers tiny implants to lift and hold prostate tissue out of the way, thus opening the urethra. The permanent implants keep the tissue in place, like tiebacks on a window curtain.
The UroLift Device is removed, leaving an open urethra for urine to flow
For more information about UroLift System treatment, contact us or click here for frequently asked questions.